排序方式: 共有24条查询结果,搜索用时 15 毫秒
1.
《Chronobiology international》2013,30(3):459-466
Many asthmatic patients experience aggravation of symptoms overnight resulting in disruption of their sleep. Sustained-release theophylline represents at this time a major bronchodilator medication which possesses a sufficient duration of activity to avert the nocturnal breathing distress of asthma. Circadian rhythm-adapted theophylline schedules consisting of unequal dosing—more or all the drug taken in the evening—have proven efficacious in clinical investigations for certain patients. Although the kinetic behavior of some formulations is affected by food, the circadian rhythm-adapted schedules represent a significant step forward toward the goal of optimizating sustained-release theophyllines for patients who experience nighttime symptoms. 相似文献
2.
Uveitis is a potentially sight-threatening inflammatory eye disease caused by multiple infectious and non-infectious etiologies for which the standard of care involves corticosteroids or various immunomodulary therapy (IMT) drugs. These available treatments, although effective, may cause significant morbidity and sometimes mortality in uveitis patients due to their toxic side-effects and the necessity of long-term therapy to prevent recurrences. In order to avoid the systemic toxicity ofcorticosteroids and IMT or the repeated injections of local steroids necessary to control ocular inflammation, and to prevent development of cumulative damage resulting from recurrent episodes of inflammation, researchers have developed a number of local corticosteroid sustained-release devices that can be implanted directly into the vitreous of the eye, at the site of the inflammatory disease. Preliminary studies of such a device, the fluocinolone acetonide (Retisert) implant, have shown significant reductions in the number of inflammatory episodes and decreased reliance on systemic corticosteroids or other IMT. This review explores the current research evaluating the fluocinolone sustained-release intravitreal implant in the treatment of posterior uveitis and the implications for its future use on a wider scale. 相似文献
3.
采用后组装法将非水溶性的治疗冠心病药物槲皮素组装进入MCM-41介孔分子筛的孔道中,药物组装率达37%[m(药物)/m(药物总量)],用XRD,扫描电镜和IR对药物组装体进行了表征;通过测定组装体在体外模拟人工小肠液中的溶出速率,表明制得了槲皮素/MCM-41缓释体系。 相似文献
4.
目的:探讨非洛地平缓释片对轻中度原发性高血压患者的降压疗效和对脉搏波速度的影响。方法:根据纳入标准选取我院260例原发性高血压患者,按计划方案给予非洛地平缓释片口服治疗。观察患者入院后、治疗2周末、14周末降压疗效及脉搏波传导速度的改变情况,并进行对比分析。结果:本组研究中接受治疗研究者共260例,其所有受检者在治疗2、6、10、14周后血压水平均有不同程度改善,与基线比较差异明显,有统计学意义(P〈0,01)。脉搏波变化分析所有受试者脉搏波速度变化分析,基线脉搏波速度为(10.9±2.4)m/s,经过治疗后2周、14周基线脉搏波速度为(10.3±2.1)m/s,差异明显具有统计学意义(P〈0.01);心率变化分析表明非洛地平缓释片在降压同时对心率影响不大,安全性评价表示,接受治疗期间曾有68例发生不良事件,占总数26.2%。笔者认为与药物无关,且均为轻度,经过适当处理后均缓解,对本研究无影响。结论:非洛地平缓释片降压效果良好,可同时降低颈动脉.股动脉脉搏波传导速度,改善大动脉僵硬度。 相似文献
5.
The objective of this work was to develop matrix sustained-release tablets of highly water-soluble tramadol HCl using natural
gums (xanthan [X gum] and guar [G gum]) as cost-effective, nontoxic, easily available, and suitable hydrophilic matrix systems
compared with the extensively investigated hydrophilic matrices (ie, hydroxypropyl methylcellulose [HPMC]/carboxymethyl cellulose
[CMC] with respect to in vitro drug release rate) and hydration rate of the polymers. Matrix tablets of tramadol (dose 100
mg) were produced by direct compression method. Different ratios, of 100∶0, 80∶20, 60∶40, 20∶80, 0∶100 of G gum (or X):HPMC,
X gum:G gum, and triple mixture of these polymers (G gum, X gum, HPMC) were applied. After evaluation of physical characteristics
of tablets, the dissolution test was, performed in the phosphate buffer media (pH 7.4) up to 8 hours. Tablets with only X
had the highest mean dissolution time (MDT), the least dissolution efficiency (DE8%), and released the drug following a zero-order model via swelling, diffusion, and erosion mechanisms. Guar gum alone could
not efficiently control the drug release, while X and all combinations of natural gums with HPMC could retard tramadol HCl
release. However, according to the similarity factor (f
2), pure HPMC and H8G2 were the most similar formulations to Topalgic-LP as the reference standard.
Published: March 17, 2006 相似文献
6.
制备复合生长因子的缓释微球并考察其对细胞的影响 总被引:1,自引:0,他引:1
目的:制备复合碱性成纤维细胞生长因子的可降解缓释微球,考察其生物活性保存情况,以及其对上皮细胞的作用。方法:采用改良的乳化冷凝法交联制备明胶缓释微球,将其加入上皮细胞的培养液中,用细胞计数法、四甲基偶氮唑盐微量反应比色法(MTT法)测定细胞增殖情况。结果:缓释微球平均粒径12.36±3.56μm;培养1 d后各组细胞计数、吸光度(D)值差异均无显著性意义;5d后,缓释微球组细胞计数、吸光度(D)值明显高于对照组;7 d后,缓释微球组值仍高于其它组,但差异无显著性意义。结论:复合生长因子的缓释微球制备工艺简便,成球性好;能较长时间持续释放活性生长因子,明显促进细胞增殖。 相似文献
7.
8.
光动力疗法与给药微针(microneedle, MN)相结合为治疗肿瘤提供了一种安全有效的途径。本文设计了一种基于壳聚糖搭载高能光子的可控缓释型载药微针贴片(LED-losartan-HEMA/ CS-MN, LLH-CSMN),重点研究了其制备工艺,并且以氯沙坦为模型药物对微针阵列的形貌尺寸进行了表征,探究了LLH-CSMN的力学性能、皮肤穿刺性能、缓释性能以及高能光子在长时间工作下的光热性能。结果表明,基于壳聚糖搭载高能光子的微针贴片能够有效地在皮肤表面打开通道进行药物递送,并进行光动力治疗。同时,体外透皮扩散试验表明,以氯沙坦为模型药物制备的微针在1 h内释放了约30%的药物,在1 d内总共释放了约60%的药物,随后进行缓慢释放,在6 d后最终释放了93%的药物,LLH-CSMN具有可控缓释特性以及良好的长效光辅助治疗效果,为肿瘤治疗提供了一个新的安全有效途径。 相似文献
9.
The purpose of this work was to investigate the effect of different polysulfonate resins and direct compression fillers on
physical properties of multiple-unit sustained-release dextromethorphan (DMP) tablets. DMP resinates were formed by a complexation
of DMP and strong cation exchange resins, Dowex 50 W and Amberlite IRP69. The tablets consisted of the DMP resinates and direct
compression fillers, such as microcrystalline cellulose (MCC), dicalcium phosphate dihydrate (DCP), and spray-dried rice starch
(SDRS). Physical properties of tablets, such as hardness, disintegration time, and in vitro release, were investigated. A
good performance of the tablets was obtained when MCC or SDRS was used. The use of rod-like and plate-like particles of Amberlite
IRP69 caused a statistical decrease in tablet hardness, whereas good tablet hardness was obtained when spherical particle
of Dowex 50 W was used. The plastic deformation of the fillers, such as MCC and SDRS, caused a little change in the release
of DMP. A higher release rate constant was found in the tablets containing DCP and Dowex 50 W, indicating the fracture of
the resinates under compression, which was attributable to the fragmentation of DCP. However, the release of DMP from the
tablets using Amberlite IRP69 was not significantly changed because of the higher degree of cross-linking of the resinates,
which exhibited more resistance to deformation under compression. In conclusion, the properties of polysulfonate resin, such
as particle shape and degree of cross-linking, and the deformation under compaction of fillers affect the physical properties
and the drug release of the resinate tablets.
Published: September 30, 2005. 相似文献
10.
本文以非甾体抗炎药吲哚美辛为模型药物制备了骨架型缓释片剂,以体外溶出为检验指标,考察了甲壳胺的脱乙酰度、表观粘度及用量对药物释放的影响,并确定了甲壳胺的脱乙酰度及粘度范围。实验结果表明,缓释作用随脱乙酰度升高而降低;随用量增多而增强;粘度对药物释放的影响随脱乙酰度不同而不同。脱乙酰度为85%的甲壳胺,其缓释作用随表观粘度的增大而增大;脱乙酰度为75%的甲壳胺缓释作用随粘度升高而降低。 相似文献